More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Generic Pharmaceuticals Price Fixing
Antitrust, Health Care, Healthcare
Lowey Dannenberg represents 34 of the nation’s largest health insurers, including Elevance Health (formerly known as Anthem), Aetna, Humana, and 25 BlueCross BlueShield licensees in connection with their claims relating […]

Swiss Franc LIBOR
Antitrust
Lowey Dannenberg is the court-appointed sole lead counsel in a class action against numerous global financial institutions responsible for setting the London Interbank Offered Rate for the Swiss Franc (Swiss […]

Euribor
Antitrust
Lowey Dannenberg is leading the prosecution against the global financial institutions responsible for the setting of the Euro Interbank Offered Rate (“Euribor”), a global reference rate used to benchmark, price […]
News
Lowey Dannenberg Investigates Claims on Behalf of Investors of K12 Inc. (LRN) and Encourages Investors to Contact the Firm
NEW YORK, October 21, 2020 — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating claims of violations of federal securities laws on behalf of investors of K12 Inc. (“K12” or the “Company”) (NYSE: LRN). K12…
Blog
SEC Whistleblower Program Set for Banner Year
On April 16, 2020, the Securities and Exchange Commission (“SEC”) awarded $27 million to a whistleblower who provided information that led to an SEC enforcement action. This was the largest award of 2020 and the sixth largest award since the SEC Whistleblower Program began in 2011. While the order…





